Earnings ·
Humana raises full-year adjusted EPS guidance to at least $9.50 on strong third-quarter results
HUMHumana Inc
Humana reported a GAAP diluted earnings per share of $1.33 for the quarter ended September 30, 2026, compared to $1.62 in the prior year period. The company raised its full-year 2026 adjusted EPS guidance to at least $9.50 from at least $9.00 and revised GAAP EPS guidance to at least $15.09 from at least $6.52. Insurance segment benefit ratio came in at 93.7 percent, favorable to management's expectation of slightly above 94 percent. The company also highlighted continued strategic expansion in its CenterWell primary care and Medicaid footprints. Humana Inc. is a leading U.S. healthcare company providing insurance services and health care delivery through its Humana and CenterWell segments.